Multiple Sclerosis

An immune attack on the insulation around nerve fibers in the brain and spinal cord. Few conditions attract more confident dietary claims, and few have a wider gap between what the observational evidence suggests and what the trials have shown. Diet can help how you feel. It does not replace disease-modifying treatment, and nothing here is worth a relapse.

Neurological & Mental Health Evidence-Based

Last updated:

🚨 Never stop or delay a disease-modifying treatment because a diet or supplement seems to be helping. These medicines reduce relapses and the accumulation of disability, and some cannot simply be restarted without risk; stopping certain treatments abruptly has been followed by severe rebound disease activity. Contact your MS team promptly for new or worsening neurological symptoms lasting more than a day, and for any new weakness, vision loss or bladder or bowel change. Call 911 for sudden weakness or numbness in an arm, sudden loss of vision or sudden balance problems. Relapses are treatable and the window matters.

What Is Multiple Sclerosis?

A condition in which the immune system damages myelin, the insulating sheath around nerve fibers in the brain and spinal cord, and damages the fibers themselves. Signals slow or fail, and what that looks like depends entirely on where the damage is, which is why no two people describe the same illness.

Most people begin with a relapsing pattern: episodes of new symptoms lasting days to weeks, then partial or full recovery. Over time, some move to a more gradually progressive course. Modern treatment has changed this substantially, and it works best started early.

The largest recent finding is not nutritional. A study following millions of young adults found infection with Epstein-Barr virus greatly increased the subsequent risk of MS, and the authors describe it as the leading cause1. Vitamin D, adolescent weight and smoking sit alongside it as contributors to risk.

💡 Key Insight, and it is the honest tension on this page. Genetic evidence supports low vitamin D as a causal factor in developing MS2. Yet a randomized trial of high-dose vitamin D added to existing treatment did not meet its primary outcome3. Correcting something that raises your risk of getting a disease is not automatically a treatment for having it.
Diagram of a nerve fiber comparing an intact myelin sheath with a damaged patchy sheath under immune attack, showing a signal traveling quickly along one and slowing along the other

☀️ Vitamin D: risk, not treatment

Mendelian randomization supports a causal role for low vitamin D in MS risk2. Supplementation in established MS has not delivered the matching benefit3.

🧠 Diet may help fatigue

A network meta-analysis found several dietary patterns reduced fatigue and improved quality of life, while warning the underlying trials were of low quality4.

🚬 Smoking changes the course

Smoking is associated both with developing MS and with faster progression78. It is the modifiable factor with the least controversy attached to it.

Multiple Sclerosis by the Numbers

2.8 million
people estimated to be living with MS worldwide; the average age at diagnosis is 32 5
2.8ร—
the ratio of women to men with MS in a national US estimate6
32-fold
rise in MS risk after Epstein-Barr virus infection, in a cohort of more than 10 million young adults; other viruses showed no such rise1
About 2ร—
the chance of developing MS in people who smoke7, and smoking also speeds the progression of disability8
12 trials
of vitamin D in 933 people with MS found no effect on relapses, disability or MRI lesions at one year, on very low-quality evidence9
24 hours
new or worsening symptoms lasting longer than this, without an infection, may be a relapse: contact your MS team promptly8

Symptoms of Multiple Sclerosis

MS shows up differently in everyone, because the symptoms depend on where the damage is.

SymptomWhat happens
Vision loss or pain in one eyeBlurring or dimming over hours to days, pain on moving the eye. Worth knowing: Call 911 if vision is lost or blurred suddenly7; otherwise contact your MS team promptly. Optic neuritis is a common first presentation and is treatable.
New numbness, tingling or weaknessOften on one side, or a band around the trunk, lasting more than a day. Worth knowing: Report it. A relapse treated early is managed better than one reported late. If weakness or numbness in an arm comes on suddenly, call 911 7.
FatigueOut of proportion to activity, worse as the day goes on. Worth knowing: The symptom people most often rank as their worst, and the one diet research has actually targeted.
Balance and coordination difficultyUnsteadiness, clumsiness, tremor. Worth knowing: Responds to rehabilitation more than most people are told.
Bladder and bowel changesUrgency, frequency, incomplete emptying, constipation. Worth knowing: Very common, very treatable and under-reported through embarrassment.
Cognitive changeProcessing speed, memory, word-finding. Worth knowing: Real and measurable. Worth naming rather than absorbing.
Worsening in heatSymptoms returning in hot weather, a hot bath or with fever. Worth knowing: Usually not a relapse. It typically settles when you cool down. A true relapse persists.
Spasticity and painStiffness, spasms, nerve pain. Worth knowing: Treatable, and worth raising specifically since it is often assumed to be unavoidable.
⚠️ Learn the difference between a relapse and a bad day, because it changes what you should do. A relapse is a new or clearly worsening symptom lasting more than 24 hours without infection or fever, and it needs reporting. Symptoms that flare in heat, with an infection or when you are exhausted, and then settle, are usually not new damage. An infection, a urinary one especially, can make old symptoms return convincingly. If in doubt, contact your MS team rather than deciding alone.

Causes of Multiple Sclerosis

MS happens when the immune system attacks the brain and nerves; it is not clear exactly why, but several factors raise the risk7.

CauseHow It Contributes to Multiple SclerosisWhat Helps
Epstein-Barr virusIn a cohort of more than 10 million young adults, MS risk rose 32-⁠fold after infection with this common virus, which causes mononucleosis (mono), and not after other viruses1Nothing on this page changes it; after diagnosis, disease-modifying treatment is what reduces relapses and how serious they are7
Low vitamin DGenetically lower vitamin D went with higher MS risk, about double the odds for each standard deviation lower2Correcting a deficiency, for bone health, as the supplement section says; vitamin D is not a treatment for MS8
SmokingPeople who smoke are about twice as likely to develop MS7, and smoking speeds the progression of disability8Stopping smoking, as the treatment section lists
Obesity in adolescenceObesity at age 18 went with more than twice the risk of MS in two large cohorts of women10A healthy weight, reached gradually, as the diet section describes; losing weight after diagnosis has not been shown to change the course of MS10
Sex, age and familyMS is more likely in women, between ages 20 and 50, and with a parent, brother or sister who has it7These cannot be changed; what helps is reporting new symptoms promptly, as the signs section describes

How Multiple Sclerosis Is Diagnosed

By a neurologist, and the nutritional part is a small and specific piece of it.

TestWhat it shows
MRI of brain and spinal cordLesions, their distribution and whether new activity is present. Worth knowing: Lesion count correlates only loosely with how someone actually functions.
Neurological examinationWhere the damage is showing, and change over time. Worth knowing: Fatigue and cognitive symptoms are poorly captured by it.
Lumbar puncture where neededSupporting evidence for the diagnosis. Worth knowing: Not required in every case.
25-⁠OH-D (vitamin D)Whether you are deficient, checked where it is suspected; a deficiency is worth correcting for bone health11. Worth knowing: Correcting it is not an established treatment for MS: an add-on trial in established MS missed its main goal3, and a 2025 trial after a first episode found fewer new lesions on MRI with a high dose given under specialist care, though relapses did not differ significantly12.
B12 and thyroid functionConditions that can mimic or compound MS symptoms. Worth knowing: See B12 and folate deficiency and thyroid disorders.
Bone health assessmentFracture risk, raised by reduced mobility and by steroid courses. Worth knowing: Frequently overlooked in a younger population. See osteoporosis.
Swallowing assessment where indicatedWhether eating is becoming unsafe, which changes nutrition entirely. Worth knowing: Ask for it if coughing on food or drink has started.
Mood and fatigue assessmentTwo of the largest contributors to how life actually goes. Worth knowing: Both treatable, and both regularly left out of a neurology appointment.
💡 The most useful nutrition question in MS is not which diet. It is whether your vitamin D is genuinely low, whether your bone health is being watched, whether swallowing is safe, and whether constipation and fatigue are being treated rather than tolerated. Those are answerable, and they change daily life.

Conventional and Holistic Treatment for Multiple Sclerosis

🌿 HOLISTIC
💊 CONVENTIONAL
🌿

Holistic / Functional Approach

Fatigue, function and general health, alongside treatment rather than instead of it

Where Diet Has Shown Something
Fatigue and quality of life. A network meta-analysis found Mediterranean, low-fat and Paleolithic patterns reduced fatigue against control4
The Caveat the Authors Themselves Give
The findings are driven by low-quality trials and must be confirmed by better ones4
Timeline
Weeks to months for fatigue. No dietary pattern has been shown to reduce relapses or disability
Limitation, stated plainly
None of this is disease-modifying, and treating it as though it were is the specific harm this page exists to prevent

Full Holistic Approach Includes

  • Taking your disease-modifying treatment, which is the most important thing on this list and belongs at the top of it.
  • Stopping smoking, associated both with developing MS and with faster progression of disability8.
  • A Mediterranean pattern, which performed well for fatigue and is sustainable, unlike some of the alternatives4.
  • Correcting vitamin D deficiency, for bone health, while being clear it is not a treatment3.
  • Regular exercise within your capacity, which may help fatigue and does not harm MS8.
  • Managing weight, since higher body weight in adolescence is associated with MS risk10 and excess weight worsens fatigue and mobility.
  • Fiber and fluid for constipation, which is extremely common and worsens bladder symptoms and spasticity.
  • Keeping cool in hot weather, which prevents the temporary worsening that heat produces.
🌿 Worth knowing: the strongest named MS diets are also the most restrictive, and restriction has a cost in a condition where fatigue already makes cooking hard. A pattern you can sustain for years beats a stricter one abandoned in three months, and the trial evidence is not strong enough to justify the harder road.

Evidence-Based Supplements for Multiple Sclerosis

Vitamin D is the entry everyone asks about, and the honest answer has two halves.

🚨 No supplement is disease-modifying in MS, and none replaces your treatment. This is the most dangerous topic on the page, because MS attracts more confident supplement marketing than almost any other condition and the cost of believing it is measured in relapses that do not reverse. Never reduce or stop a disease-modifying treatment because a supplement seems to be helping, and tell your neurology team about everything you take.
SupplementWhat it is forTypical rangeTimingNotes & cautions
Vitamin D3 Correcting deficiency, and bone health. Genetic evidence supports low vitamin D as a causal factor in MS risk2, while a randomized trial of high-dose vitamin D added to existing treatment did not meet its primary outcome3. Set a daily dose with your clinician; most adults need no blood test first With a fat-containing meal Correcting a cause of risk is not automatically a treatment. Avoid large intermittent doses and self-escalation. The adult upper intake level is 4,000 IU a day; go above it only if your clinician is correcting a deficiency. See osteoporosis for the vitamin D cautions.
Calcium and vitamin D together, if on repeated steroids Protecting bone, since repeated steroid courses and reduced mobility both raise fracture risk. Discuss with your clinician, who may also assess fracture risk Calcium with meals Relevant to many people with MS and routinely overlooked in a younger population. See osteoporosis.
B12, if deficient Correcting a deficiency whose neurological symptoms overlap with MS and which is treatable in its own right. Set by your clinician on the basis of blood results As advised Worth separating from MS rather than folding into it. See B12 and folate deficiency.
Omega-⁠3 capsules Not established as changing the course of MS. Widely taken, but the NICE guideline advises against omega-⁠3 or omega-⁠6 compounds to treat MS, finding no evidence that they affect relapses or progression8. Not recommended for multiple sclerosis (the NICE guideline advises against it) Not applicable May be appropriate for other reasons agreed on with your clinician. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day13, so check any fish oil supplement with your clinician first. Fatty fish as food is part of the dietary pattern that did help fatigue.
🚨 What to avoid, specifically. Any protocol that asks you to stop, delay or taper disease-modifying treatment, which is the one genuinely dangerous thing in this field. Very high-dose vitamin D regimens taken without monitoring, which can cause dangerously high calcium. Products claiming to remyelinate or reverse MS, none of which does. Unregulated stem cell clinics marketed directly to patients. Supplement stacks assembled without anyone checking them against your medicines and liver monitoring. And any diet so restrictive that you are eating less overall.
💡 Where the real leverage is. Taking your disease-modifying treatment consistently, stopping smoking, reporting new symptoms within days rather than weeks, getting rehabilitation for function and eating a sustainable pattern that leaves you enough energy for the rest of it. Those five have far stronger evidence than any supplement.

What to Expect Over Time

MS cannot yet be stopped, but treatments slow its progression and ease symptoms, and most people with MS live into old age7.

Treatment and supportive care, together
First Weeks

A neurologist confirms the diagnosis from your history, an examination, MRI and laboratory tests, and you should have one named point of contact for your care8.

Months 1 to 3

Disease-modifying treatment starts, to reduce how many relapses you have and how serious they are7. Exercise is encouraged, since it may help and does not harm MS, and so is not smoking, since smoking speeds disability8.

Months 3 to 12

Relapses that affect daily tasks are assessed and treated within 14 days, and not every relapse needs steroids8. Fatigue, bladder, movement and mood problems each have their own treatment7. A healthy diet helps general health; small, low-quality trials suggest some diets may ease fatigue, but none is proven to8.

Long Term

Relapsing-remitting MS often develops into secondary progressive MS, and treatment changes over time7.

When to Seek Care

Contact your MS team promptly if new symptoms appear, or old ones worsen, for more than 24 hours without a fever or infection: this may be a relapse8. Call 911 for sudden weakness or numbness in an arm, sudden loss or blurring of vision, or sudden balance problems7.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Treatment Comes First in MS

Diet can help how you feel. It does not replace disease-modifying treatment, and nothing here is worth a relapse. Exercise is encouraged, and so is not smoking, since smoking speeds disability.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.14 This page is nutrition education, not medical advice, and it does not replace your doctor. No diet and no supplement is disease-modifying in multiple sclerosis. The dietary evidence that exists is about fatigue and quality of life, it comes from small trials whose own authors call for better ones, and it says nothing about relapses or disability. Nothing here replaces disease-modifying treatment, and stopping that treatment because something else seems to be helping is the most dangerous thing associated with this topic. What nutrition education can do is help you understand the evidence well enough to have a better conversation with the clinician who does treat you.

  1. Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296-⁠301. PubMed 35025605. A cohort of more than ten million young adults, in which Epstein-Barr virus infection greatly increased the subsequent risk of multiple sclerosis. Included so that a reader arriving with the impression that MS is caused by diet has the current picture of what actually drives risk. ↩
  2. Mokry LE, Ross S, Ahmad OS, et al. Vitamin D and risk of multiple sclerosis: a Mendelian randomization study. PLoS Med. 2015;12(8):e1001866. PubMed 26305103. Genetically lowered vitamin D level was associated with increased susceptibility to multiple sclerosis. Mendelian randomization supports a causal role in risk of developing the disease, which is a different question from whether supplementation treats established disease. Cited together with the trial below because the pair is the honest picture. ↩
  3. Hupperts R, Smolders J, Vieth R, et al. Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon beta-⁠1a. Neurology. 2019;93(20):e1906-⁠e1916. PubMed 31594857. SOLAR did not establish a benefit on its primary outcome, although exploratory MRI outcomes suggested some protective effect. A Cochrane review of 12 trials in 933 people found no effect of vitamin D on relapses, disability or MRI lesions at one year, on very low-quality evidence, PubMed 30246874. A later trial that randomized 316 untreated people with a first episode typical of MS (303 in the main analysis) found that very high doses every two weeks, given with trial monitoring, reduced disease activity, mostly new lesions on MRI, but did not significantly reduce relapses, PubMed 40063041. This is why the page frames vitamin D as correcting a deficiency rather than as a treatment, despite the strength of the risk evidence above. ↩
  4. Snetselaar LG, Cheek JJ, Fox SS, et al. Efficacy of diet on fatigue and quality of life in multiple sclerosis: a systematic review and network meta-analysis of randomized trials. Neurology. 2023;100(4):e357-⁠e366. PubMed 36257717. Twelve trials, eight dietary interventions, 608 participants. Paleolithic, low-fat and Mediterranean diets each reduced fatigue compared with control, with improvements in quality of life. The authors state that the findings are driven by the low quality of the included trials and must be confirmed in high-quality randomized trials, which this page quotes rather than omits. The NICE guideline on MS, weighing the evidence, advises telling people that there is no evidence a specific diet will improve fatigue, but that a healthy diet benefits general health, NICE NG220. ↩
  5. On how many people have MS: the third Atlas of MS estimated that 2.8 million people live with MS worldwide, that the average age at diagnosis is 32, and that women are about twice as likely as men to live with MS, PubMed 33174475. ↩
  6. On MS in the United States: a national estimate from health insurance data found about 309 adults per 100,000 had MS, 450 per 100,000 women and 160 per 100,000 men, a ratio of 2.8 to 1, with prevalence highest at ages 55 to 64 and falling from north to south, PubMed 30770430. ↩
  7. On causes and care: NHS guidance states that MS happens when the immune system attacks the brain and nerves and that it is not clear why; that it is more likely between ages 20 and 50, in women, with a parent, brother or sister who has it, in people who smoke (about twice as likely) and after Epstein-Barr virus infection; that it cannot yet be stopped, but treatments slow its progression and ease symptoms, including disease-modifying therapies that reduce how many relapses people have and how serious they are; that relapsing remitting MS often develops into secondary progressive MS; that most people with MS live into old age; and that sudden weakness or numbness in an arm, sudden loss or blurring of vision, or sudden balance problems need emergency care, NHS, multiple sclerosis. ↩
  8. On diagnosis, relapse and what does not treat MS: the NICE guideline on MS defines a relapse as new or worsening symptoms lasting more than 24 hours without infection or another cause, after at least a month of stability; advises assessing and treating relapses that affect daily tasks as early as possible and within 14 days, noting that not all relapses need steroids; advises a single point of contact for care, encouraging exercise, which may help MS-related fatigue and does not harm MS, and not smoking, which speeds disability; and advises against vitamin D solely to treat MS and against omega-⁠3 or omega-⁠6 compounds to treat it, finding no evidence that they affect relapses or progression, and that there is no evidence a specific diet improves fatigue, though a healthy diet benefits general health, NICE NG220. ↩
  9. On vitamin D in people who already have MS: a Cochrane review of 12 randomized trials in 933 people found that vitamin D had no effect on relapses, disability or MRI lesions at one year and was safe at the doses tested, on very low-quality evidence, PubMed 30246874. ↩
  10. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009;73(19):1543-⁠1550. PubMed 19901245. Higher body size in adolescence was associated with increased risk of multiple sclerosis. Cited as a risk factor rather than as a treatment target, since losing weight after diagnosis has not been shown to change the disease course. ↩
  11. On vitamin D and bone: MedlinePlus states that vitamin D helps the body absorb calcium, one of the main building blocks of bone, and that a lack of vitamin D can lead to bone diseases such as osteoporosis or rickets, MedlinePlus, Vitamin D. ↩
  12. Thouvenot E, et al. High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial. JAMA. 2025;333(16):1413-⁠1422. PubMed 40063041. In 303 untreated adults within 90 days of a first episode typical of MS, a high dose of vitamin D3 taken every two weeks for two years left fewer with disease activity than placebo (60.3% against 74.1%, hazard ratio 0.66), mostly through fewer new or enhancing lesions on MRI; relapses alone did not differ significantly (hazard ratio 0.69, 0.42 to 1.16). It is one trial, at a dose far above the everyday upper limit and given only under specialist supervision, and a trial after a first episode that used daily doses found no benefit (PubMed 38085047). ↩
  13. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
  14. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu. ↩